DOGG vs. THNR ETF Comparison

Comparison of FT CBOE Vest DJIA Dogs 10 Target Income ETF (DOGG) to Amplify Weight Loss Drug & Treatment ETF (THNR)
DOGG

FT CBOE Vest DJIA Dogs 10 Target Income ETF

DOGG Description

Under normal market conditions, the fund will pursue its objective by investing primarily in common stocks, exchange-traded options (including FLexible EXchange options (FLEX Options)) and short-term U.S. Treasury securities. The fund seeks to provide exposure to a concentrated portfolio of large-capitalization U.S. equity securities while providing a consistent level of income that is approximately 8% (before fees and expenses) above the annualized yield of the Dow Jones Industrial Average ("DJIA"). The fund is non-diversified.

Grade (RS Rating)

Last Trade

$19.72

Average Daily Volume

11,884

Number of Holdings *

10

* may have additional holdings in another (foreign) market
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$22.58

Average Daily Volume

2,478

Number of Holdings *

15

* may have additional holdings in another (foreign) market
Performance
Period DOGG THNR
30 Days -8.13% -12.44%
60 Days -5.77% -16.42%
90 Days -3.32% -14.44%
12 Months 6.74%
1 Overlapping Holdings
Symbol Grade Weight in DOGG Weight in THNR Overlap
AMGN D 4.74% 5.07% 4.74%
Compare ETFs